Keymakr news
The latest Keymakr news, : Medical AI expands into rare‑disease drug discovery and virtual lab markets.
2 stories mentioning Keymakr since 18 September 2026, newest first, each with its sources and discussion. Follow to see new ones on your front page.
-
Medical AI expands into rare‑disease drug discovery and virtual lab markets
DeepMind’s AlphaFold has predicted more than 200 million protein structures, giving AI‑driven drug discovery startups a large data foundation. Recursion Pharmaceuticals, a US biotech, reports encouraging Phase 1b/2…
1 sourceUnite.AI -
Opinion: When Does a Business Become AI‑Native, Not Just AI‑Enabled?
The author argues that simply using large‑language‑model tools like Gemini, ChatGPT, Grok or Claude does not make a company AI‑native. A true AI‑native business would see its core product or service collapse if the AI…
1 sourceUnite.AI
Questions about Keymakr
What is the latest Keymakr news?
As of 20 October 2026: Medical AI expands into rare‑disease drug discovery and virtual lab markets. DeepMind’s AlphaFold has predicted more than 200 million protein structures, giving AI‑driven drug discovery startups a large data foundation.